C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis

Metabolic outcomes in type 1 diabetes remain suboptimal. Disease modifying therapy to prevent β-cell loss presents an alternative treatment framework but the effect on metabolic outcomes is unclear. We, therefore, aimed to define the relationship between insulin C-peptide as a marker of β-cell funct...

Celý popis

Podrobná bibliografie

Vydáno v:	The lancet. Diabetes & endocrinology Ročník 11; číslo 12; s. 915
Hlavní autoři:	Taylor, Peter N, Collins, Kimberly S, Lam, Anna, Karpen, Stephen R, Greeno, Brianna, Walker, Frank, Lozano, Alejandro, Atabakhsh, Elnaz, Ahmed, Simi T, Marinac, Marjana, Latres, Esther, Senior, Peter A, Rigby, Mark, Gottlieb, Peter A, Dayan, Colin M
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 01.12.2023
Témata:	Adult C-Peptide - therapeutic use Child Cross-Sectional Studies Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 1 - drug therapy Glycated Hemoglobin Humans Hypoglycemic Agents - therapeutic use Insulin - therapeutic use
ISSN:	2213-8595, 2213-8595
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!